13F Holdings
中文EN

RA CAPITAL MANAGEMENT, L.P.

BOSTON MA · SEC CIK 0001346824

2026Q22026Q1 9 earlier quarters 🔒
$11.51B2026Q2 reported value
84Positions
60.4%Top 10 weight · largest 23.8%
11 / 17New / sold out
Reported value over time$11.51B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

ASND 23.8%
PBLS 6.9%
RYTM 6.4%
PCVX 5.8%
SION 3.8%
TYRA 3.4%
EWTX 3.0%
NAMS 2.8%
COAG 2.5%
SEPN 2.0%

2026Q2 top buys estimated at quarter-end value

ABVX New+$150.92M
ORKA New+$147.95M
ARTV Added+$78.59M
NTLA New+$76.60M
DFTX New+$70.56M

2026Q2 top sells estimated at quarter-end value

DNTH Sold out-$219.18M
NUVALENT INC-A Reduced-$159.03M
PRAX Sold out-$120.43M
SRPT Sold out-$84.92M
EWTX Reduced-$82.71M

2026Q2 holdings click a header to sort · 100 rows per page

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
ASND ASCENDIS PHARMA A/S $2.74B23.83%10,281,496 00.0% — Unchanged
PBLS PARABILIS MEDICINES INC $791.91M6.88%28,933,371 28,933,371— — First reported
RYTM RHYTHM PHARMACEUTICALS INC $740.22M6.43%6,666,837 00.0% — Unchanged
PCVX VAXCYTE INC $667.02M5.80%11,474,599 00.0% — Unchanged
SION SIONNA THERAPEUTICS INC $435.72M3.79%9,905,045 00.0% — Unchanged
TYRA TYRA BIOSCIENCES INC $389.62M3.39%12,198,625 00.0% — Unchanged
EWTX EDGEWISE THERAPEUTICS INC $341.00M2.96%8,392,730 -2,035,707-19.5% -$82.71M Reduced
NAMS NEWAMSTERDAM PHARMA CO NV $323.66M2.81%9,550,191 00.0% — Unchanged
COAG HEMAB THERAPEUTICS HOLDINGS $286.81M2.49%7,808,627 7,808,627— — First reported
SEPN SEPTERNA INC $234.29M2.04%6,995,858 00.0% — Unchanged
BCAX BICARA THERAPEUTICS INC $215.43M1.87%7,255,993 00.0% — Unchanged
MLYS MINERALYS THERAPEUTICS INC $207.55M1.80%7,692,750 00.0% — Unchanged
GHRS GH RESEARCH PLC $205.28M1.78%7,636,813 -39,884-0.5% -$1.07M Reduced
IRON DISC MEDICINE INC $179.21M1.56%2,450,221 00.0% — Unchanged
SGP SPYGLASS PHARMA INC $178.55M1.55%8,021,117 00.0% — Unchanged
ARTV ARTIVA BIOTHERAPEUTICS INC $174.17M1.51%17,955,642 8,102,34082.2% $78.59M Added
JANX JANUX THERAPEUTICS INC $171.87M1.49%11,189,693 00.0% — Unchanged
TSHA TAYSHA GENE THERAPIES INC $160.41M1.39%23,555,648 00.0% — Unchanged
BCRX BIOCRYST PHARMACEUTICALS INC $158.27M1.38%15,827,186 00.0% — Unchanged
WVE WAVE LIFE SCIENCES LTD $156.73M1.36%26,975,505 00.0% — Unchanged
— NUVALENT INC-A $153.94M1.34%1,246,456 -1,287,689-50.8% -$159.03M Reduced
ABVX ABIVAX SA-ADR $150.92M1.31%1,132,557 1,132,557— $150.92M New
ORKA ORUKA THERAPEUTICS INC $147.95M1.29%1,554,597 1,554,597— $147.95M New
CLYM CLIMB BIO INC $147.36M1.28%11,300,939 00.0% — Unchanged
SLDB SOLID BIOSCIENCES INC $120.24M1.04%12,036,126 2,696,14828.9% $26.93M Added
ZLAB ZAI LAB LTD-ADR $109.13M0.95%5,743,533 36,2710.6% $689,149 Added
SPRY ARS PHARMACEUTICALS INC $87.00M0.76%10,860,977 00.0% — Unchanged
XNCR XENCOR INC $84.92M0.74%5,274,274 377,0377.7% $6.07M Added
JBIO JADE BIOSCIENCES INC $81.57M0.71%3,671,083 00.0% — Unchanged
NTLA INTELLIA THERAPEUTICS INC $76.60M0.67%4,526,926 4,526,926— $76.60M New
LBRX LB PHARMACEUTICALS INC $71.68M0.62%2,208,604 00.0% — Unchanged
DFTX DEFINIUM THERAPEUTICS INC $70.56M0.61%1,500,000 1,500,000— $70.56M New
ACRS ACLARIS THERAPEUTICS INC $67.30M0.58%12,723,026 5,918,95487.0% $31.31M Added
FDMT 4D MOLECULAR THERAPEUTICS IN $67.16M0.58%5,049,779 00.0% — Unchanged
SANA SANA BIOTECHNOLOGY INC $65.44M0.57%18,750,000 18,750,000— $65.44M New
DMRA DAMORA THERAPEUTICS INC $62.42M0.54%2,399,702 3920.0% $10,196 Added
MNPR MONOPAR THERAPEUTICS INC $61.78M0.54%667,207 00.0% — Unchanged
— ACUMEN PHARMACEUTICALS INC $56.05M0.49%20,992,669 00.0% — Unchanged
GERN GERON CORP $54.80M0.48%42,809,751 -20,961,615-32.9% -$26.83M Reduced
RZLT REZOLUTE INC $49.11M0.43%9,445,039 265,0392.9% $1.38M Added
EVMN EVOMMUNE INC $46.44M0.40%3,494,638 00.0% — Unchanged
VOR VOR BIOPHARMA INC $44.22M0.38%2,402,095 -3,002,903-55.6% -$55.28M Reduced
IPSC CENTURY THERAPEUTICS INC $43.50M0.38%17,754,430 00.0% — Unchanged
AKTS AKTIS ONCOLOGY INC $42.36M0.37%1,314,405 -188,679-12.6% -$6.08M Reduced
BIOA BIOAGE LABS INC $40.97M0.36%1,671,648 21,0001.3% $514,710 Added
CCCC C4 THERAPEUTICS INC $37.36M0.32%8,000,000 00.0% — Unchanged
MIRM MIRUM PHARMACEUTICALS INC $37.29M0.32%318,554 00.0% — Unchanged
CAPR CAPRICOR THERAPEUTICS INC $36.31M0.32%1,507,844 00.0% — Unchanged
— PEPGEN INC $36.12M0.31%20,064,545 00.0% — Unchanged
PRLD PRELUDE THERAPEUTICS INC $34.52M0.30%6,475,882 6,475,882— $34.52M New
NKTX NKARTA INC $30.58M0.27%10,805,129 00.0% — Unchanged
QTTB Q32 BIO INC $29.72M0.26%2,332,457 2,332,457— $29.72M New
AVR ANTERIS TECHNOLOGIES GLOBAL $29.55M0.26%3,000,000 00.0% — Unchanged
EDIT EDITAS MEDICINE INC $28.80M0.25%8,889,000 8,889,000— $28.80M New
OVID OVID THERAPEUTICS INC $28.25M0.25%10,500,968 -213,032-2.0% -$573,056 Reduced
ASMB ASSEMBLY BIOSCIENCES INC $28.04M0.24%1,020,410 00.0% — Unchanged
ALXO ALX ONCOLOGY HOLDINGS INC $26.93M0.23%13,011,849 00.0% — Unchanged
BNTC BENITEC BIOPHARMA INC $24.75M0.22%1,850,000 00.0% — Unchanged
LENZ LENZ THERAPEUTICS INC $23.74M0.21%4,178,823 00.0% — Unchanged
LXEO LEXEO THERAPEUTICS INC $23.27M0.20%5,000,000 00.0% — Unchanged
— ACRIVON THERAPEUTICS INC $21.77M0.19%12,229,396 3,888,88846.6% $6.92M Added
ALT ALTIMMUNE INC $19.76M0.17%6,500,000 6,500,000— $19.76M New
KPTI KARYOPHARM THERAPEUTICS INC $18.73M0.16%1,917,354 00.0% — Unchanged
DRUG BRIGHT MINDS BIOSCIENCES INC $18.60M0.16%265,000 00.0% — Unchanged
AVTX AVALO THERAPEUTICS INC $18.48M0.16%1,000,000 337,03250.8% $6.23M Added
OKUR ONKURE THERAPEUTICS INC-A $18.23M0.16%3,998,333 00.0% — Unchanged
FTH FAETH THERAPEUTICS INC $18.05M0.16%722,020 722,020— $18.05M New
AURA AURA BIOSCIENCES INC $17.75M0.15%2,500,000 2,500,000— $17.75M New
SABS SAB BIOTHERAPEUTICS INC $17.17M0.15%4,401,500 00.0% — Unchanged
SPTX SEAPORT THERAPEUTICS INC $15.20M0.13%700,000 700,000— — First reported
PALI PALISADE BIO INC $14.89M0.13%7,124,116 00.0% — Unchanged
HLXC HELIX ACQUISITION CORP-CL A $13.30M0.12%1,250,000 00.0% — Unchanged
WAY WAYSTAR HOLDING CORP $10.87M0.09%529,400 00.0% — Unchanged
EQ EQUILLIUM INC $9.91M0.09%3,096,336 00.0% — Unchanged
MGNX MACROGENICS INC $8.61M0.07%1,864,176 00.0% — Unchanged
— PERCEPTIVE CAPITAL SOLUTIONS $8.16M0.07%750,000 00.0% — Unchanged
— ADICET BIO INC $8.06M0.07%932,624 -250,000-21.1% -$2.16M Reduced
— NEWAMSTERDAM PHARMA CO NV-27 $7.12M0.06%333,333 00.0% — Unchanged
CRVS CORVUS PHARMACEUTICALS INC $6.72M0.06%450,000 00.0% — Unchanged
— RANI THERAPEUTICS HOLDINGS-A $6.46M0.06%8,500,000 00.0% — Unchanged
— JATT II ACQUISITION CORP $5.68M0.05%500,000 500,000— — First reported
— AMANAT ACQUISITION CORP CL A $3.81M0.03%375,000 375,000— — First reported
— WEREWOLF THERAPEUTICS INC $859,3490.01%2,387,744 -4,293,563-64.3% -$1.55M Reduced
— PALATIN TECHNOLOGIES INC $670,3180.01%62,124 -7,876-11.3% -$84,982 Reduced
DNTH DIANTHUS THERAPEUTICS INC $00.00%0 -2,611,733-100.0% -$219.18M Sold out
PRAX PRAXIS PRECISION MEDICINES I $00.00%0 -373,787-100.0% -$120.43M Sold out
SRPT SAREPTA THERAPEUTICS INC $00.00%0 -3,902,596-100.0% -$84.92M Sold out
SYRE SPYRE THERAPEUTICS INC $00.00%0 -1,621,620-100.0% -$81.79M Sold out
FULC FULCRUM THERAPEUTICS INC $00.00%0 -6,053,960-100.0% -$46.43M Sold out
OLMA OLEMA PHARMACEUTICALS INC $00.00%0 -2,600,000-100.0% -$38.77M Sold out
DSGN DESIGN THERAPEUTICS INC $00.00%0 -2,972,973-100.0% -$31.63M Sold out
TVTX TRAVERE THERAPEUTICS INC $00.00%0 -746,841-100.0% -$22.19M Sold out
GRAL GRAIL INC $00.00%0 -428,266-100.0% -$22.13M Sold out
RLMD RELMADA THERAPEUTICS INC $00.00%0 -2,947,369-100.0% -$20.51M Sold out
STRO SUTRO BIOPHARMA INC $00.00%0 -715,307-100.0% -$17.82M Sold out
CTNM CONTINEUM THERAPEUTICS INC-A $00.00%0 -1,296,012-100.0% -$16.93M Sold out
INSP INSPIRE MEDICAL SYSTEMS INC $00.00%0 -325,663-100.0% -$16.80M Sold out
HNGE HINGE HEALTH INC-A $00.00%0 -364,613-100.0% -$14.06M Sold out
WGS GENEDX HOLDINGS CORP $00.00%0 -209,887-100.0% -$13.48M Sold out
RNA ATRIUM THERAPEUTICS INC $00.00%0 -864,102-100.0% -$11.55M Sold out